Mylan says cost cutting plan will impact up to 10% of its staff
Mylan NV has announced a restructuring plan that it says will impact less than 10% of its workforce.
Archives for December 7, 2016
Troubled Halol plant earns Sun a US FDA Form 483
The US FDA has issued Sun Pharmaceutical Industries with a Form 483 citing problems identified at its plant in Halol.
MilliporeSigma to speed up production of Acticor’s antibody against stroke
Acticor Biotech has made a deal with Merck KGaA’s CMO MilliporeSigma to use its Provantage End-to-End services to make its anti-thrombotic antibody fragment ACT-017 for stroke.
Needle-free Zika vaccine shows promise in clinical trial
As part of its collaboration with the National Institutes of Health (NIH) in the DNA vaccine clinical trial for the Zika virus, PharmaJet is providing its Stratis Needle-Free device and training to the NIH.
Almac, inVentiv announce strategic partnership
Almac Clinical Technologies, part of the Almac Group, has announced a strategic partnership with the contract research organization (CRO) inVentiv Health.
Lonza to sell therapeutic peptides business to PolyPeptide
Lonza has agreed to sell its therapeutic peptide business to PolyPeptide Laboratories in a deal that will also see the latter firm take on 280 staff.
Hamlet Pharma partners with European CRO, Neox Clinical Research
Hamlet Pharma has signed an agreement with Neox Clinical Research to advance the company’s Phase II bladder cancer study in Prague, Czech Republic.